Innovation abounds in the biopharmaceutical industry. But not every innovation is nurtured to fruition. The future of a great idea often comes down to whether the founding scientists can assemble the best team and access ample funding to move it forward.
Your life-science startup might have breakthrough science and a rock-star team, but as long as the company is “new,” it’s inherently at high risk of failure.
If you had to choose an industry that lends itself to poor corporate reputation, it very well may be commercial airlines. Customers have been dragged off of planes, employees have resigned in dramatic fashion, and operational meltdowns seem the norm.